Ontology type: schema:ScholarlyArticle
1992-03
AUTHORSXosé R. Bustelo, Jeffrey A. Ledbetter, Mariano Barbacid
ABSTRACTSEVERAL proteins implicated in the regulation of cellular responses to mitogenic stimuli contain a common non-catalytic domain, SH2 (for src-homologous domain 2), that mediates their interaction with activated tyrosine protein kinases. Here we report that p95vav, a proto-oncogene product specifically expressed in cells of the haematopoietic system, contains an SH2 domain and is a substrate for tyrosine protein kinases. Exposure of quiescent NIH3T3 cells ectopically expressing p95vav to either epidermal or platelet-derived growth factors induces the rapid phosphorylation of this protein on tyrosine residues. Activation of the receptors for these growth factors by their cognate ligand results in their association with p95vav, a process mediated by its SH2 domain. In T cells, co-activation of the T-cell receptor and the accessory CD4 cell-surface protein also results in the phosphorylation of the endogenous p95vav protein in tyrosine residues. Phosphorylation of p95vav is rapid, transient and precedes the appearance of most other phosphotyrosine-containing proteins. In addition to the SH2 domain, p95vav contains structural motifs not found in other tyrosine kinase substrates. One such motif is a helix–loop–helix/leucine zipper-like domain which shares some sequence similarity with these motifs in the Myc and Max proteins. Deletion of the helix–loop–helix-like motif causes oncogenic activation of p95vav. These results indicate that p95vav is a new type of signal transduction molecule and suggest a possible role for this protein in the transduction of tyrosine phosphorylation signalling into transcriptional events. More... »
PAGES68-71
http://scigraph.springernature.com/pub.10.1038/356068a0
DOIhttp://dx.doi.org/10.1038/356068a0
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1049189454
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/1311423
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Biological Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Biochemistry and Cell Biology",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Animals",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Blotting, Western",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "CD4 Antigens",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cell Line",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "ErbB Receptors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Mice",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Oncogene Protein pp60(v-src)",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Oncogene Proteins",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Phosphorylation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Protein-Tyrosine Kinases",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Proto-Oncogene Proteins c-vav",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Receptors, Antigen, T-Cell",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Receptors, Cell Surface",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Receptors, Platelet-Derived Growth Factor",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Signal Transduction",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Molecular Biology, Bristol\u2013Myers Squibb Pharmaceutical Research Institute, PO Box 4000, 08543-4000, Princeton, New Jersey, USA",
"id": "http://www.grid.ac/institutes/grid.419971.3",
"name": [
"Department of Molecular Biology, Bristol\u2013Myers Squibb Pharmaceutical Research Institute, PO Box 4000, 08543-4000, Princeton, New Jersey, USA"
],
"type": "Organization"
},
"familyName": "Bustelo",
"givenName": "Xos\u00e9 R.",
"id": "sg:person.01225402207.85",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225402207.85"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Molecular Sciences, Bristol\u2013Myers Squibb Pharmaceutical Research Institute, PO Box 4000, 08543-4000, Princeton, New Jersey, USA",
"id": "http://www.grid.ac/institutes/grid.419971.3",
"name": [
"Department of Molecular Sciences, Bristol\u2013Myers Squibb Pharmaceutical Research Institute, PO Box 4000, 08543-4000, Princeton, New Jersey, USA"
],
"type": "Organization"
},
"familyName": "Ledbetter",
"givenName": "Jeffrey A.",
"id": "sg:person.01142240266.56",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142240266.56"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Molecular Biology, Bristol\u2013Myers Squibb Pharmaceutical Research Institute, PO Box 4000, 08543-4000, Princeton, New Jersey, USA",
"id": "http://www.grid.ac/institutes/grid.419971.3",
"name": [
"Department of Molecular Biology, Bristol\u2013Myers Squibb Pharmaceutical Research Institute, PO Box 4000, 08543-4000, Princeton, New Jersey, USA"
],
"type": "Organization"
},
"familyName": "Barbacid",
"givenName": "Mariano",
"id": "sg:person.0101555544.84",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0101555544.84"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1038/356071a0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044711278",
"https://doi.org/10.1038/356071a0"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/344345a0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1047932838",
"https://doi.org/10.1038/344345a0"
],
"type": "CreativeWork"
}
],
"datePublished": "1992-03",
"datePublishedReg": "1992-03-01",
"description": "SEVERAL proteins implicated in the regulation of cellular responses to mitogenic stimuli contain a common non-catalytic domain, SH2 (for src-homologous domain 2), that mediates their interaction with activated tyrosine protein kinases. Here we report that p95vav, a proto-oncogene product specifically expressed in cells of the haematopoietic system, contains an SH2 domain and is a substrate for tyrosine protein kinases. Exposure of quiescent NIH3T3 cells ectopically expressing p95vav to either epidermal or platelet-derived growth factors induces the rapid phosphorylation of this protein on tyrosine residues. Activation of the receptors for these growth factors by their cognate ligand results in their association with p95vav, a process mediated by its SH2 domain. In T cells, co-activation of the T-cell receptor and the accessory CD4 cell-surface protein also results in the phosphorylation of the endogenous p95vav protein in tyrosine residues. Phosphorylation of p95vav is rapid, transient and precedes the appearance of most other phosphotyrosine-containing proteins. In addition to the SH2 domain, p95vav contains structural motifs not found in other tyrosine kinase substrates. One such motif is a helix\u2013loop\u2013helix/leucine zipper-like domain which shares some sequence similarity with these motifs in the Myc and Max proteins. Deletion of the helix\u2013loop\u2013helix-like motif causes oncogenic activation of p95vav. These results indicate that p95vav is a new type of signal transduction molecule and suggest a possible role for this protein in the transduction of tyrosine phosphorylation signalling into transcriptional events.",
"genre": "article",
"id": "sg:pub.10.1038/356068a0",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1018957",
"issn": [
"0028-0836",
"1476-4687"
],
"name": "Nature",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "6364",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "356"
}
],
"keywords": [
"tyrosine protein kinase",
"SH2 domain",
"kinase substrate",
"protein kinase",
"tyrosine residues",
"leucine zipper-like domain",
"protein kinase substrates",
"tyrosine kinase substrate",
"non-catalytic domain",
"phosphotyrosine-containing proteins",
"quiescent NIH3T3 cells",
"signal transduction molecules",
"proto-oncogene product",
"cell surface proteins",
"Max protein",
"platelet-derived growth factor",
"sequence similarity",
"growth factor",
"transcriptional events",
"like motif",
"tyrosine phosphorylation",
"transduction molecules",
"rapid phosphorylation",
"NIH3T3 cells",
"oncogenic activation",
"p95vav",
"cellular responses",
"phosphorylation",
"CD4 cell surface protein",
"haematopoietic system",
"protein",
"such motifs",
"motif",
"mitogenic stimuli",
"structural motifs",
"kinase",
"cell receptor",
"residues",
"possible role",
"cells",
"domain",
"ligand results",
"SH2",
"activation",
"transduction",
"Vav",
"receptors",
"Myc",
"substrate",
"helix",
"deletion",
"regulation",
"similarity",
"molecules",
"role",
"new class",
"interaction",
"factors",
"products",
"response",
"events",
"addition",
"stimuli",
"exposure",
"association",
"results",
"types",
"process",
"class",
"appearance",
"system",
"new type"
],
"name": "Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates",
"pagination": "68-71",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1049189454"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1038/356068a0"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"1311423"
]
}
],
"sameAs": [
"https://doi.org/10.1038/356068a0",
"https://app.dimensions.ai/details/publication/pub.1049189454"
],
"sdDataset": "articles",
"sdDatePublished": "2022-06-01T21:59",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_252.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1038/356068a0"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/356068a0'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/356068a0'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/356068a0'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/356068a0'
This table displays all metadata directly associated to this object as RDF triples.
218 TRIPLES
22 PREDICATES
116 URIs
106 LITERALS
22 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1038/356068a0 | schema:about | N03c8c2f4bcbf4c5089748de7d7b48b7a |
2 | ″ | ″ | N0d1461e2ea3a4b01ab53c4c201d0515e |
3 | ″ | ″ | N12b3d1cfadb04b7cb351ba60594d31d0 |
4 | ″ | ″ | N1ac1c25eca844bc58c0ccb6cee33a28e |
5 | ″ | ″ | N3c15225b86dc4fb9a61c48d68d01f4ad |
6 | ″ | ″ | N40f479ed601a46428eaecba37f9903cc |
7 | ″ | ″ | N4609bd254f8a41fb8e55b8ab6b5069be |
8 | ″ | ″ | N4f33bcb89e4448bc9251152f3594c9c4 |
9 | ″ | ″ | N60fa26fca4254f9b970a437c7f4c50ac |
10 | ″ | ″ | N663118b699414fb7a94b071d3a5dd6b2 |
11 | ″ | ″ | N6c3d505f66284f748df86c17f55ebe90 |
12 | ″ | ″ | N6e726d6b747047d298b053a41c0291a3 |
13 | ″ | ″ | Nce3442eea2b648a7a7e27ba0001fc8b0 |
14 | ″ | ″ | Nce82725abc364ce98f76b7e68ca10b71 |
15 | ″ | ″ | Nf5a60f1eab0f4bc181f431eee09c1d1a |
16 | ″ | ″ | anzsrc-for:06 |
17 | ″ | ″ | anzsrc-for:0601 |
18 | ″ | schema:author | N8ec3c38c4da34673bfa9964831fbe7b7 |
19 | ″ | schema:citation | sg:pub.10.1038/344345a0 |
20 | ″ | ″ | sg:pub.10.1038/356071a0 |
21 | ″ | schema:datePublished | 1992-03 |
22 | ″ | schema:datePublishedReg | 1992-03-01 |
23 | ″ | schema:description | SEVERAL proteins implicated in the regulation of cellular responses to mitogenic stimuli contain a common non-catalytic domain, SH2 (for src-homologous domain 2), that mediates their interaction with activated tyrosine protein kinases. Here we report that p95vav, a proto-oncogene product specifically expressed in cells of the haematopoietic system, contains an SH2 domain and is a substrate for tyrosine protein kinases. Exposure of quiescent NIH3T3 cells ectopically expressing p95vav to either epidermal or platelet-derived growth factors induces the rapid phosphorylation of this protein on tyrosine residues. Activation of the receptors for these growth factors by their cognate ligand results in their association with p95vav, a process mediated by its SH2 domain. In T cells, co-activation of the T-cell receptor and the accessory CD4 cell-surface protein also results in the phosphorylation of the endogenous p95vav protein in tyrosine residues. Phosphorylation of p95vav is rapid, transient and precedes the appearance of most other phosphotyrosine-containing proteins. In addition to the SH2 domain, p95vav contains structural motifs not found in other tyrosine kinase substrates. One such motif is a helix–loop–helix/leucine zipper-like domain which shares some sequence similarity with these motifs in the Myc and Max proteins. Deletion of the helix–loop–helix-like motif causes oncogenic activation of p95vav. These results indicate that p95vav is a new type of signal transduction molecule and suggest a possible role for this protein in the transduction of tyrosine phosphorylation signalling into transcriptional events. |
24 | ″ | schema:genre | article |
25 | ″ | schema:inLanguage | en |
26 | ″ | schema:isAccessibleForFree | false |
27 | ″ | schema:isPartOf | Ne0aaffa617614673a224a4fd83308116 |
28 | ″ | ″ | Ne1b815eca20e46059ae1dcc466449996 |
29 | ″ | ″ | sg:journal.1018957 |
30 | ″ | schema:keywords | CD4 cell surface protein |
31 | ″ | ″ | Max protein |
32 | ″ | ″ | Myc |
33 | ″ | ″ | NIH3T3 cells |
34 | ″ | ″ | SH2 |
35 | ″ | ″ | SH2 domain |
36 | ″ | ″ | Vav |
37 | ″ | ″ | activation |
38 | ″ | ″ | addition |
39 | ″ | ″ | appearance |
40 | ″ | ″ | association |
41 | ″ | ″ | cell receptor |
42 | ″ | ″ | cell surface proteins |
43 | ″ | ″ | cells |
44 | ″ | ″ | cellular responses |
45 | ″ | ″ | class |
46 | ″ | ″ | deletion |
47 | ″ | ″ | domain |
48 | ″ | ″ | events |
49 | ″ | ″ | exposure |
50 | ″ | ″ | factors |
51 | ″ | ″ | growth factor |
52 | ″ | ″ | haematopoietic system |
53 | ″ | ″ | helix |
54 | ″ | ″ | interaction |
55 | ″ | ″ | kinase |
56 | ″ | ″ | kinase substrate |
57 | ″ | ″ | leucine zipper-like domain |
58 | ″ | ″ | ligand results |
59 | ″ | ″ | like motif |
60 | ″ | ″ | mitogenic stimuli |
61 | ″ | ″ | molecules |
62 | ″ | ″ | motif |
63 | ″ | ″ | new class |
64 | ″ | ″ | new type |
65 | ″ | ″ | non-catalytic domain |
66 | ″ | ″ | oncogenic activation |
67 | ″ | ″ | p95vav |
68 | ″ | ″ | phosphorylation |
69 | ″ | ″ | phosphotyrosine-containing proteins |
70 | ″ | ″ | platelet-derived growth factor |
71 | ″ | ″ | possible role |
72 | ″ | ″ | process |
73 | ″ | ″ | products |
74 | ″ | ″ | protein |
75 | ″ | ″ | protein kinase |
76 | ″ | ″ | protein kinase substrates |
77 | ″ | ″ | proto-oncogene product |
78 | ″ | ″ | quiescent NIH3T3 cells |
79 | ″ | ″ | rapid phosphorylation |
80 | ″ | ″ | receptors |
81 | ″ | ″ | regulation |
82 | ″ | ″ | residues |
83 | ″ | ″ | response |
84 | ″ | ″ | results |
85 | ″ | ″ | role |
86 | ″ | ″ | sequence similarity |
87 | ″ | ″ | signal transduction molecules |
88 | ″ | ″ | similarity |
89 | ″ | ″ | stimuli |
90 | ″ | ″ | structural motifs |
91 | ″ | ″ | substrate |
92 | ″ | ″ | such motifs |
93 | ″ | ″ | system |
94 | ″ | ″ | transcriptional events |
95 | ″ | ″ | transduction |
96 | ″ | ″ | transduction molecules |
97 | ″ | ″ | types |
98 | ″ | ″ | tyrosine kinase substrate |
99 | ″ | ″ | tyrosine phosphorylation |
100 | ″ | ″ | tyrosine protein kinase |
101 | ″ | ″ | tyrosine residues |
102 | ″ | schema:name | Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates |
103 | ″ | schema:pagination | 68-71 |
104 | ″ | schema:productId | N79499369000e421484c0e8cc56d75b9c |
105 | ″ | ″ | Nbbf98d49e6954f769948525f44c09e1d |
106 | ″ | ″ | Nef4f85d19a914f28836110b7ec181d07 |
107 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1049189454 |
108 | ″ | ″ | https://doi.org/10.1038/356068a0 |
109 | ″ | schema:sdDatePublished | 2022-06-01T21:59 |
110 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
111 | ″ | schema:sdPublisher | N3df8221f141b4331b36b8af5ab02609a |
112 | ″ | schema:url | https://doi.org/10.1038/356068a0 |
113 | ″ | sgo:license | sg:explorer/license/ |
114 | ″ | sgo:sdDataset | articles |
115 | ″ | rdf:type | schema:ScholarlyArticle |
116 | N03c8c2f4bcbf4c5089748de7d7b48b7a | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
117 | ″ | schema:name | Signal Transduction |
118 | ″ | rdf:type | schema:DefinedTerm |
119 | N0d1461e2ea3a4b01ab53c4c201d0515e | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
120 | ″ | schema:name | ErbB Receptors |
121 | ″ | rdf:type | schema:DefinedTerm |
122 | N12b3d1cfadb04b7cb351ba60594d31d0 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
123 | ″ | schema:name | Cell Line |
124 | ″ | rdf:type | schema:DefinedTerm |
125 | N1ac1c25eca844bc58c0ccb6cee33a28e | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
126 | ″ | schema:name | Protein-Tyrosine Kinases |
127 | ″ | rdf:type | schema:DefinedTerm |
128 | N3c15225b86dc4fb9a61c48d68d01f4ad | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
129 | ″ | schema:name | Proto-Oncogene Proteins c-vav |
130 | ″ | rdf:type | schema:DefinedTerm |
131 | N3df8221f141b4331b36b8af5ab02609a | schema:name | Springer Nature - SN SciGraph project |
132 | ″ | rdf:type | schema:Organization |
133 | N40f479ed601a46428eaecba37f9903cc | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
134 | ″ | schema:name | Receptors, Antigen, T-Cell |
135 | ″ | rdf:type | schema:DefinedTerm |
136 | N4609bd254f8a41fb8e55b8ab6b5069be | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
137 | ″ | schema:name | Mice |
138 | ″ | rdf:type | schema:DefinedTerm |
139 | N4f33bcb89e4448bc9251152f3594c9c4 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
140 | ″ | schema:name | Phosphorylation |
141 | ″ | rdf:type | schema:DefinedTerm |
142 | N60fa26fca4254f9b970a437c7f4c50ac | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
143 | ″ | schema:name | Receptors, Platelet-Derived Growth Factor |
144 | ″ | rdf:type | schema:DefinedTerm |
145 | N663118b699414fb7a94b071d3a5dd6b2 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
146 | ″ | schema:name | CD4 Antigens |
147 | ″ | rdf:type | schema:DefinedTerm |
148 | N6c3d505f66284f748df86c17f55ebe90 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
149 | ″ | schema:name | Receptors, Cell Surface |
150 | ″ | rdf:type | schema:DefinedTerm |
151 | N6e726d6b747047d298b053a41c0291a3 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
152 | ″ | schema:name | Animals |
153 | ″ | rdf:type | schema:DefinedTerm |
154 | N79499369000e421484c0e8cc56d75b9c | schema:name | pubmed_id |
155 | ″ | schema:value | 1311423 |
156 | ″ | rdf:type | schema:PropertyValue |
157 | N8ec3c38c4da34673bfa9964831fbe7b7 | rdf:first | sg:person.01225402207.85 |
158 | ″ | rdf:rest | Nc99f894ba5f84b5cb96579d637f1b70e |
159 | Nbbf98d49e6954f769948525f44c09e1d | schema:name | doi |
160 | ″ | schema:value | 10.1038/356068a0 |
161 | ″ | rdf:type | schema:PropertyValue |
162 | Nc99f894ba5f84b5cb96579d637f1b70e | rdf:first | sg:person.01142240266.56 |
163 | ″ | rdf:rest | Ne479adf2e79243afb88f7cfd33ed4d44 |
164 | Nce3442eea2b648a7a7e27ba0001fc8b0 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
165 | ″ | schema:name | Blotting, Western |
166 | ″ | rdf:type | schema:DefinedTerm |
167 | Nce82725abc364ce98f76b7e68ca10b71 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
168 | ″ | schema:name | Oncogene Protein pp60(v-src) |
169 | ″ | rdf:type | schema:DefinedTerm |
170 | Ne0aaffa617614673a224a4fd83308116 | schema:issueNumber | 6364 |
171 | ″ | rdf:type | schema:PublicationIssue |
172 | Ne1b815eca20e46059ae1dcc466449996 | schema:volumeNumber | 356 |
173 | ″ | rdf:type | schema:PublicationVolume |
174 | Ne479adf2e79243afb88f7cfd33ed4d44 | rdf:first | sg:person.0101555544.84 |
175 | ″ | rdf:rest | rdf:nil |
176 | Nef4f85d19a914f28836110b7ec181d07 | schema:name | dimensions_id |
177 | ″ | schema:value | pub.1049189454 |
178 | ″ | rdf:type | schema:PropertyValue |
179 | Nf5a60f1eab0f4bc181f431eee09c1d1a | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
180 | ″ | schema:name | Oncogene Proteins |
181 | ″ | rdf:type | schema:DefinedTerm |
182 | anzsrc-for:06 | schema:inDefinedTermSet | anzsrc-for: |
183 | ″ | schema:name | Biological Sciences |
184 | ″ | rdf:type | schema:DefinedTerm |
185 | anzsrc-for:0601 | schema:inDefinedTermSet | anzsrc-for: |
186 | ″ | schema:name | Biochemistry and Cell Biology |
187 | ″ | rdf:type | schema:DefinedTerm |
188 | sg:journal.1018957 | schema:issn | 0028-0836 |
189 | ″ | ″ | 1476-4687 |
190 | ″ | schema:name | Nature |
191 | ″ | schema:publisher | Springer Nature |
192 | ″ | rdf:type | schema:Periodical |
193 | sg:person.0101555544.84 | schema:affiliation | grid-institutes:grid.419971.3 |
194 | ″ | schema:familyName | Barbacid |
195 | ″ | schema:givenName | Mariano |
196 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0101555544.84 |
197 | ″ | rdf:type | schema:Person |
198 | sg:person.01142240266.56 | schema:affiliation | grid-institutes:grid.419971.3 |
199 | ″ | schema:familyName | Ledbetter |
200 | ″ | schema:givenName | Jeffrey A. |
201 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142240266.56 |
202 | ″ | rdf:type | schema:Person |
203 | sg:person.01225402207.85 | schema:affiliation | grid-institutes:grid.419971.3 |
204 | ″ | schema:familyName | Bustelo |
205 | ″ | schema:givenName | Xosé R. |
206 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225402207.85 |
207 | ″ | rdf:type | schema:Person |
208 | sg:pub.10.1038/344345a0 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1047932838 |
209 | ″ | ″ | https://doi.org/10.1038/344345a0 |
210 | ″ | rdf:type | schema:CreativeWork |
211 | sg:pub.10.1038/356071a0 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1044711278 |
212 | ″ | ″ | https://doi.org/10.1038/356071a0 |
213 | ″ | rdf:type | schema:CreativeWork |
214 | grid-institutes:grid.419971.3 | schema:alternateName | Department of Molecular Biology, Bristol–Myers Squibb Pharmaceutical Research Institute, PO Box 4000, 08543-4000, Princeton, New Jersey, USA |
215 | ″ | ″ | Department of Molecular Sciences, Bristol–Myers Squibb Pharmaceutical Research Institute, PO Box 4000, 08543-4000, Princeton, New Jersey, USA |
216 | ″ | schema:name | Department of Molecular Biology, Bristol–Myers Squibb Pharmaceutical Research Institute, PO Box 4000, 08543-4000, Princeton, New Jersey, USA |
217 | ″ | ″ | Department of Molecular Sciences, Bristol–Myers Squibb Pharmaceutical Research Institute, PO Box 4000, 08543-4000, Princeton, New Jersey, USA |
218 | ″ | rdf:type | schema:Organization |